Fedha

Hisa unazofuatilia
0775:HKG
CK Life Sciences Intl (Holdings) Inc
HK$ 0.51
0.00%
(0.00) Siku 1
16 Okt, 16:08:14 GMT +8  ·   HKD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya 0775...
Fungua
HK$ 0.51
Juu
HK$ 0.52
Chini
HK$ 0.51
Mtaji wa soko
4.90B
Wastani wa kiasi cha mauzo
1.66M
Kiasi cha mauzo ya hisa
elfu 956.00
Juu kwa wiki 52
HK$ 1.02
Chini kwa wiki 52
HK$ 0.51
EPS
-HK$ 0.01
Hisa za wawekezaji
9.61B
Idadi ya wafanyakazi
elfu 2
Fungua
HK$ 0.51
Juu
HK$ 0.52
Chini
HK$ 0.51
Mtaji wa soko
4.90B
Wastani wa kiasi cha mauzo
1.66M
Kiasi cha mauzo ya hisa
elfu 956.00
Juu kwa wiki 52
HK$ 1.02
Chini kwa wiki 52
HK$ 0.51
EPS
-HK$ 0.01
Hisa za wawekezaji
9.61B
Idadi ya wafanyakazi
elfu 2
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings. It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008. CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector. The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
Kuhusu CK Life Sciences Intl (Holdings) Inc
Afisa Mkuu Mtendaji (CEO)Ying Choi Yu
Wafanyakazielfu 1.92
Lilianzishwa2000
Makao makuu-
Sekta-
Ripoti za awaliThamani zote katika HKD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika HKD
Sep 2025
Des 2025
Mac 2026
Jun 2026
Mapato
1.40B
1.40B
1.36B
1.36B
Gharama ya bidhaa zilizouzwa
1.01B
1.01B
975.61M
975.61M
Gharama ya mapato
1.01B
1.01B
975.61M
975.61M
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
187.01M
187.01M
173.47M
173.47M
Gharama ya uendeshaji
440.32M
440.32M
339.26M
339.26M
Jumla ya gharama za uendeshaji
1.45B
1.45B
1.31B
1.31B
Mapato ya uendeshaji
-48.67M
-48.67M
43.01M
43.01M
Mapato mengine yasiyo ya uendeshaji
16.60M
16.60M
9.78M
9.78M
EBT ikijumuisha vipengee visivyo vya kawaida
58.42M
58.42M
-9.29M
-9.29M
EBT bila kujumuisha vipengee visivyo vya kawaida
-87.93M
-87.93M
-9.29M
-9.29M
Gharama ya kodi ya mapato
77.23M
77.23M
15.02M
15.02M
Kiwango cha kodi kinachotumika
132.19%
132.19%
-161.72%
-161.72%
Gharama nyingine za uendeshaji
231.88M
231.88M
143.42M
143.42M
Mapato halisi
-17.98M
-17.98M
-14.36M
-14.36M
Kiwango cha faida halisi
-1.28%
-1.28%
-1.06%
-1.06%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
5.36M
5.36M
3.26M
3.26M
Gharama ya riba
-61.80M
-61.80M
-65.24M
-65.24M
Jumla ya gharama halisi za riba
-56.44M
-56.44M
-61.97M
-61.97M
Gharama za kushuka kwa thamani na za kulipa deni
20.80M
20.80M
21.66M
21.66M
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
11.09M
11.09M
65.38M
65.38M
Faida au hasara kutokana na uuzaji wa vipengee
-346.73M
-346.73M
-
-
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google